TSL-15098

N/A

Report date: 2025/06/11 11:11:28
NME

Base Information

Drug NameTSL-15098
Drug Alias Namesecond-generation TRK inhibitor (Chongqing Fochon Pharmaceuticals)QHL-15121TSL-15098
ClassificationSmall molecules
Mechanisms of ActionTropomyosin-related kinase inhibitorsAnticancer protein kinase inhibitors
TargetsTropomyosin-related kinase
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesFochon Pharmaceuticals Ltd
China Registration ClassN/A

Develop Information

Active CompaniesFochon Pharmaceuticals Ltd
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A